Gianni Cappelli
Overview
Explore the profile of Gianni Cappelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alfano G, Cazzato S, Diotallevi L, Giaroni F, Fontana F, Giovanella S, et al.
Clin Nephrol
. 2024 Jul;
102(3):144-153.
PMID: 38953545
Background: Telemedicine has been widely used to deliver healthcare to outpatients during the COVID-19 pandemic. The effectiveness of this modality is unclear in patients with a pre-dialysis stage of chronic...
2.
Di Chiaro G, Alfano G, Cancelli Y, Cannito F, Pulizzi R, Stipo L, et al.
G Ital Nefrol
. 2024 Jun;
41(3).
PMID: 38943331
The centralized preparation and distribution system of acidic concentrate represents a true innovation in hemodialysis, when compared to acid bags, in terms of convenience and eco-sustainability. The aim of this...
3.
Albertazzi V, Fontana F, Giberti S, Aiello V, Battistoni S, Catapano F, et al.
J Nephrol
. 2023 Nov;
37(2):471-482.
PMID: 37957455
Background: Since primary membranous nephropathy is a heterogeneous disease with variable outcomes and multiple possible therapeutic approaches, all 13 Nephrology Units of the Italian region Emilia Romagna decided to analyze...
4.
Alfano G, Fontana F, Ferrari A, Morisi N, Gregorini M, Cappelli G, et al.
Clin Kidney J
. 2023 Feb;
15(8):1450-1454.
PMID: 36824062
Safe and timely discontinuation of quarantine of in-center hemodialysis (HD) patients with a previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a challenging issue for the nephrological community...
5.
Alfano G, Perrone R, Fontana F, Ligabue G, Giovanella S, Ferrari A, et al.
Life (Basel)
. 2022 Nov;
12(11).
PMID: 36362879
The process of aging population will inevitably increase age-related comorbidities including chronic kidney disease (CKD). In light of this demographic transition, the lack of an age-adjusted CKD classification may enormously...
6.
Alfano G, Fontana F, Giovanella S, Morisi N, Amurri A, Ligabue G, et al.
Clin Exp Nephrol
. 2022 Nov;
27(2):171-178.
PMID: 36326942
Introduction: There are limited data on the effects of COVID-19 on peritoneal dialysis (PD) patients. This study aimed to describe the impact of COVID-19 on the PD population. Methods: A...
7.
Alfano G, Scarmignan R, Amurri A, Fontana F, Giovanella S, Ligabue G, et al.
In Vivo
. 2022 Oct;
36(6):2823-2827.
PMID: 36309377
Background/aim: COVID-19 is a concerning issue among in-center hemodialysis (HD) patients. To prevent COVID-19 diffusion in our HD facility, weekly rapid nasal antigen test screening was performed for all asymptomatic...
8.
Alfano G, Scarmignan R, Morisi N, Fontana F, Giovanella S, Ligabue G, et al.
Int J Nephrol
. 2022 Sep;
2022:4678717.
PMID: 36160837
Introduction: Patients receiving in-center hemodialysis are extremely vulnerable to COVID-19. It is unclear if routine screening of asymptomatic hemodialysis patients is an effective strategy to prevent COVID-19 outbreaks within the...
9.
Fontana F, Cazzato S, Giaroni F, Bertolini F, Alfano G, Mori G, et al.
J Nephrol
. 2022 Sep;
36(2):475-483.
PMID: 36131134
Background: Although discontinuation of antiplatelet agents at least 5 days before kidney biopsy is commonly recommended, the evidence behind this practice is of low level. Indeed, few non-randomized studies previously...
10.
Vries J, van Gelder M, Cappelli G, Bajo Rubio M, Verhaar M, Gerritsen K
Semin Dial
. 2022 Jun;
35(6):481-497.
PMID: 35650168
Clinical application of continuous flow peritoneal dialysis (CFPD) has been explored since the 1960s, but despite anticipated clinical benefits, CFPD has failed to gain a foothold in clinical practice, among...